Brainsway (BWAY) Income from Continuing Operations (2018 - 2026)
Brainsway (BWAY) posted quarterly Income from Continuing Operations of 2290000.0 for Q1 2026, up 106.87% year-on-year from 1107000.0 in Q1 2025, and down 31.13% on a QoQ basis from 3325000.0 in Q4 2025.
Brainsway (BWAY) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has reported Income from Continuing Operations for 9 consecutive years, with 2290000.0 the latest figure, recorded in Q1 2026.
- Quarterly Income from Continuing Operations rose 106.87% year-over-year to 2290000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 9208000.0 (up 135.08% YoY) and the FY2025 annual result came in at 7575000.0, up 159.33% from the prior year.
- Income from Continuing Operations slipped to 2290000.0 in Q1 2026 per BWAY's latest filing, from 3325000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for BWAY reached as high as 3325000.0 in Q4 2025 and fell as low as 5039000.0 in Q3 2022.
- A 5-year average of 253529.41 and a median of 127000.0 in 2023 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations tumbled 187.08% — and 2024, when it jumped 1118.9%.
- Year by year, Income from Continuing Operations stood at 3867000.0 in 2022, then surged by 103.28% to 127000.0 in 2023, then soared by 1118.9% to 1548000.0 in 2024, then soared by 114.79% to 3325000.0 in 2025, then slumped by 31.13% to 2290000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 2290000.0, 3325000.0, and 1566000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | 2.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.29 Mn |
| Dec 31, 2025 | 3.33 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 662,000.00 |
| Jun 30, 2024 | 600,000.00 |
| Mar 31, 2024 | 111,000.00 |
| Dec 31, 2023 | 127,000.00 |
| Sep 30, 2023 | -230,000.00 |
| Jun 30, 2023 | -1.66 Mn |
| Mar 31, 2023 | -2.43 Mn |
| Dec 31, 2022 | -3.87 Mn |
| Sep 30, 2022 | -5.04 Mn |
| Jun 30, 2022 | -2.45 Mn |
| Mar 31, 2022 | -1.99 Mn |
| Dec 31, 2021 | -1.35 Mn |
| Sep 30, 2021 | -1.80 Mn |
| Jun 30, 2021 | -1.94 Mn |